ArticleScientific reports2025
Dissolving microneedles fabricated from 3D-printed master molds for application in veterinary medicine.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Dissolving Microneedles with Smart Design-A Tool for Enhancing Skin Permeation of Naltrexone Hydrochloride.Molecules (Basel, Switzerland) · 2026Article
- 3D-Printing-Assisted Fabrication and Characterization of Pregabalin-Loaded PVA/PVP Dissolving Microneedle Arrays.Micromachines · 2026Article
- Biosensor-Integrated Microneedle Devices for Diagnosis and Treatment of Chronic and Infectious Diseases: Current Status, Trends and Challenges.Biosensors · 2026Review
- Integrating Polymeric 3D-Printed Microneedles with Wearable Devices: Toward Smart and Personalized Healthcare Solutions.Polymers · 2025Review
- Development of a 3D Printing Liquid Crystal Display (LCD)-Assisted Micromolding Methodology for Custom Fabrication of Polymeric Microneedles Using Experimental Design.Pharmaceutics · 2025Article
- Dissolvable Microneedles with Their Design, Materials, and Limitations in Translation: a Technical Review.AAPS PharmSciTech · 2025Review
- Dissolving microneedle patches for transdermal delivery of paroxetine:Therapeutic delivery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Microneedle (MN) technology is gaining popularity as it offers many benefits and advantages over the conventional drug delivery methods. The transdermal drug delivery system (TDDS) with MNs offers painless, precise, and easy-to-use solutions that can be obtained using cost-effective technologies such as 3D printing. Numerous examples of microneedle applications have been reported for human use, especially given the context of the recent pandemic and the development of vaccination technologies. However, there is limited exploration of microneedles in veterinary medicine. In the following work, we presented a proposal for the efficient production of quickly dissolving microneedle patches from PVP (polyvinylpyrrolidone) and PVA (polyvinyl alcohol) polymers based on a model microneedle array printed using DLP (Digital Light Processing) technology. We have developed a repeatable process in which the obtained microneedles can easily penetrate the outer layers of skin and quickly deliver the model drug. Such a versatile platform can be used, among others, in the treatment of animal gingival diseases, which affect a significant amount of the cat and dog population. An important advantage of the presented solution is the possibility of implementing the whole technological process in a veterinary office in a short time and the possibility of easy adjusting the size of the patches to a specific animal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.